Retatrutide (often called “Reta”) is an investigational peptide developed for weight loss, obesity, and metabolic health. It is known as a triple agonist because it targets three hormone receptors at the same time: GLP-1, GIP, and glucagon receptors. This combination is designed to help reduce appetite, improve blood sugar control, increase feelings of fullness, and boost the body’s calorie-burning ability.
Potential benefits being studied include:
- Significant weight loss
- Reduced appetite and food cravings
- Improved insulin sensitivity
- Better blood sugar regulation
- Increased fat oxidation and energy expenditure
- Possible improvements in metabolic health and fatty liver disease
Cones in crystal form.
For research purposes only.